Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpAFRA:87N +0.58%87 Days Inventory is 127.93 as of Jun. 2026, which is 21% above its 10-year median of 105.62. GuruFocus rates FRA:87N with a GF Score™ of 87/100 and a GF Value™ of €22.30 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Stevanato Group SpA ranks better than 72.84% on this metric.
The historical rank and industry rank for Stevanato Group SpA's Days Inventory or its related term are showing as below:
FRA:87N'
s Days Inventory Range Over the Past 10 Years
Min: 94.31 Med: 105.62 Max: 119.21
Current: 119.21
During the past 8 years, Stevanato Group SpA's highest Days Inventory was 119.21. The lowest was 94.31. And the median was 105.62.
FRA:87N's Days Inventory is ranked better than 72.84% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 176.755
vs FRA:87N: 119.21
Stevanato Group SpA's Days Inventory
increased
from Jun. 2025 (121.33) to Jun. 2026 (127.93).
It might indicate that Stevanato Group SpA's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Stevanato Group SpA's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.71.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Stevanato Group SpA's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.00.
Stevanato Group SpA (FRA:87N) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Stevanato Group SpA's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Stevanato Group SpA's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Stevanato Group SpA Days Inventory Related Terms
Stevanato Group SpA Days Inventory Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:87N vs MMED, TFX, MMSI: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Days Inventory distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stevanato Group SpA (FRA:87N) has a Days Inventory of 127.93 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Stevanato Group SpA and its competitors. This is 21% above median its historical median of 105.62. Over the past decade, Stevanato Group SpA's Days Inventory has ranged from 94.31 to 119.21. According to the industry distribution chart, Stevanato Group SpA ranks #214 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 27.2%.
Is Stevanato Group SpA's Days Inventory too high?
Stevanato Group SpA's current Days Inventory of 127.93 is 21% above median its 10-year median of 105.62. Over the past 10 years, this metric has ranged from a low of 94.31 to a high of 119.21. The Medical Devices & Instruments industry median Days Inventory is 176.76. Stevanato Group SpA's value of 127.93 is 27.6% below this industry median. Based on the distribution chart, Stevanato Group SpA ranks #214 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stevanato Group SpA has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Days Inventory compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #214 out of 788 companies for Days Inventory. This puts Stevanato Group SpA in the upper half of its industry. The industry median Days Inventory is 176.76. Stevanato Group SpA's value of 127.93 is 27.6% below this benchmark. Historically, Stevanato Group SpA's own Days Inventory has ranged from 94.31 to 119.21 over the past decade. While the company's 10-year median is 105.62 vs. the industry median of 176.76, Stevanato Group SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.76, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current Days Inventory of 127.93 is 27.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Stevanato Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current Days Inventory is 127.93, which is 21% above median its own 10-year median of 105.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (FRA:87N) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.30, compared to a current price of €17.40 — trading 22% below its estimated fair value. The current Days Inventory is 127.93, which is 21% above median its 10-year median of 105.62 and 27.6% below the Medical Devices & Instruments industry median of 176.76. Stevanato Group SpA's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Stevanato Group SpA (FRA:87N), the current Days Inventory is 127.93 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (FRA:87N) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of €17.40 is trading 22% below its estimated GF Value™ of €22.30.
GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.
Key valuation signals for FRA:87N:
Days Inventory: 127.93 (21% above median its 10-year median of 105.62)
GF Value™: €22.30 vs. price of €17.40 (22% below fair value)
Industry Position: 27.6% below the Medical Devices & Instruments median (#214 of 788)
No single metric tells the full story. See the FRA:87N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
87GF Score
Get the complete analysis for FRA:87N
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:87N has been successfully added to your 
